StockTipsArenaBeta

BUY Aarti Pharmalabs Limited — Nilesh Jain, Centrum Broking

BUYAarti Pharmalabs Limited

byNilesh Jain, Centrum BrokingHorizon: NA (inferred Swing (≤2wk))10 Aug 2026via NDTV Profit (Live)

Entry₹823Inferred
Target₹850
Total upside +3.28% (call closed)
Stop loss₹800-2.79% risk
Exit₹85011 Aug 2026, 9:15 am
Target hit+3.28%0.00%upside left
Follow Nilesh Jain for new calls(31% target hit, 109 closed calls)Get alertsWatch AARTIPHARM for new buy/sell callsGet alertsSee 1 active Swing call on AARTIPHARM

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Aug 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 crore

NewsEt-Markets·10 Aug · today

(opens in new tab)
Neutral / worth noting (1)

Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·7 Aug · 3d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.